Development of a rapid microparticle-enhanced turbidimetric immunoassay for plasma fatty acid-binding protein, an early marker of acute myocardial infarction

Clinical Chemistry

Volumn 44, Issue 7, 1998, Pages 1564-1567

  Robers, Markus ^a   Van Der Hulst, Ferenc F ^a   Fischer, Marc A J G ^a   Roos, Werner ^b   Salud, Carlos E ^b   Eisenwiener, Hans Georg ^b   Glatz, Jan F C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; LATEX;

ACUTE HEART INFARCTION; ARTICLE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; TURBIDIMETRY;

EID: 0031859493     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.7.1564     Document Type: Article

References (15)

1. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatine kinase the choice for the 1990's? Circulation 1993;88:750-63.
2. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991;24:195-201.
3. Kleine AH, Glatz JFC, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992;116:155-62.
4. Van Nieuwenhoven FA, Kleine AH, Wodzig KWH, Hermens WTh, Kragten HA, Maessen JG, et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995;92:2848-54.
5. Yoshimoto K, Tanaka T, Sohmiya K, Tsuji R, Okamoto F, Kawamura K, et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995;10:304-9.
6. Glatz JFC, Haastrup B, Hermens WT, de Zwaan C, Barker J, McNeil CJ, et al. Fatty acid-binding protein and the early detection of myocardial infarction: the EUROCARDI Multicenter Trial. [Abstract]. Circulation 1997;96(Suppl I): 215.
7. Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentrations of myoglobin vs heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43:1372-8.
8. Knowlton AA, Burner RE, Brecher P. Rabbit heart fatty acid-binding protein: isolation, characterization, and application of a monoclonal antibody. Circ Res 1989;65:981-8.
9. Ohkaru Y, Asayama K, Ishii H, Nishimura S, Sunahara N, Tanaka T, Kawamura K. Development of a sandwich enzyme-linked immunosorbent assay for the determination of human heart type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods 1995;178:99-111.
10. Wodzig KWH, Pelsers MMAL, Van der Vusse GJ, Roos W, Glatz, JFC. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem 1997;34:263-8.
11. Siegmann-Thoss C, Renneberg R, Glatz JFC, Spener F. Enzyme immunosensor for diagnosis of myocardial infarction. Sensors Actuators 1996;B 30:71-6.
12. Roos W, Eymann E, Symannek M, Duppenthaler J, Wodzig KWH, Pelsers MMAL, Glatz JFC. Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Methods 1995;183:149-53.
13. Van Nieuwenhoven FA, Vork MM, Surtel DAM, Kleine AH, Van der Vusse GJ, Glatz, JFC. High-yield two-step Chromatographic procedure for purification of fatty acid-binding protein from human heart. J Chromatogr 1991;570:173-9.
14. Wodzig KWH, Kragten JA, Modrzejewski W, Górski J, Van Dieijen-Visser MP, Glatz JFC, Hermens WT. Thrombolitic therapy does not change the release ratios of enzymatic and non-enzymatic myocardial marker proteins. Clin Chim Acta (in press).
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.